Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Cash from Investing Activities: 2009-2024

Historic Cash from Investing Activities for Fresenius Medical Care AG (FMS) over the last 16 years, with Dec 2024 value amounting to -$90.8 million.

  • Fresenius Medical Care AG's Cash from Investing Activities rose 73.86% to -$63.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $424.1 million, marking a year-over-year decrease of 39.57%. This contributed to the annual value of -$90.8 million for FY2024, which is 84.58% up from last year.
  • According to the latest figures from FY2024, Fresenius Medical Care AG's Cash from Investing Activities is -$90.8 million, which was up 84.58% from -$588.7 million recorded in FY2023.
  • Over the past 5 years, Fresenius Medical Care AG's Cash from Investing Activities peaked at -$90.8 million during FY2024, and registered a low of -$1.5 billion during FY2020.
  • Moreover, its 3-year median value for Cash from Investing Activities was -$588.7 million (2023), whereas its average is -$484.6 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Cash from Investing Activities dropped by 7.12% in 2021 and then skyrocketed by 84.58% in 2024.
  • Fresenius Medical Care AG's Cash from Investing Activities (MRY) stood at -$1.5 billion in 2020, then grew by 7.12% to -$1.4 billion in 2021, then surged by 45.30% to -$774.4 million in 2022, then rose by 23.98% to -$588.7 million in 2023, then surged by 84.58% to -$90.8 million in 2024.
  • Its Cash from Investing Activities was -$90.8 million in FY2024, compared to -$588.7 million in FY2023 and -$774.4 million in FY2022.